|
Tumor biopsies in high grade ovarian cancer: Clinical utility and challenges for biomarker-directed therapy. |
|
|
No Relationships to Disclose |
|
|
Employment - Clovis Oncology |
Stock and Other Ownership Interests - Clovis Oncology |
|
|
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Verastem |
Travel, Accommodations, Expenses - Clovis Oncology; Verastem |
|
|
Travel, Accommodations, Expenses - Clovis Oncology |
|
|
Employment - Clovis Oncology |
Stock and Other Ownership Interests - Clovis Oncology |
|
|
No Relationships to Disclose |
|
|
Employment - Clovis Oncology |
Stock and Other Ownership Interests - Clovis Oncology |
|
|
Employment - Clovis Oncology |
Stock and Other Ownership Interests - Clovis Oncology |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Clovis Oncology |
Stock and Other Ownership Interests - Clovis Oncology |
|
|
Employment - Clovis Oncology |
Leadership - Clovis Oncology; Epizyme |
Stock and Other Ownership Interests - Clovis Oncology; Epic Sciences; Epizyme |
Travel, Accommodations, Expenses - Epizyme |
|
|
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem |
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche |
Travel, Accommodations, Expenses - AstraZeneca; Roche |